MR13A9

· Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MR13A9, covering 2025-09-10 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus. [Phase 2]